LONDON, March 19, 2014 /PRNewswire/ --
On Tuesday, March 18, 2014, the US
markets saw a positive sentiment with the NASDAQ Composite closing
at 4,333.31, up 1.25%, the Dow Jones Industrial Average ending the
session at 16,336.19, up 0.55% and the S&P 500 edging 0.72%
higher to finish the trading session at 1,872.25. During the
session, gains in the Information Technology, Health Care, and
Energy sectors positively impacted the broader market. A number of
stocks saw large movements, including Coeur Mining Inc. (NYSE:
CDE), Eagle Rock Energy Partners L.P. (NASDAQ: EROC), Idenix
Pharmaceuticals Inc. (NASDAQ: IDIX), and WidePoint Corp. (AMEX:
WYY). Free technical research on CDE, EROC, IDIX and WYY can be
downloaded upon signing up at:
http://www.investor-edge.com/321-register
Coeur Mining Inc.'s stock finished Tuesday's session at
$11.10, recording a gain of 4.82%. A
total of 3.18 million shares traded which is above the three months
average volume of 1.72 million shares. The stock vacillated between
$10.39 and $11.25 during the session.
Shares in Coeur Mining Inc. have gained 3.93% in the previous three
trading sessions, 9.14% in the last three months and 2.30% on YTD
basis. The S&P 500 Materials Sector Index mapped a gain of
0.56% during the trading session and charted up 2.85% in the last
one month. Additionally, the stock is trading at the RSI of 45.19
and above its 50-day moving average of $10.87. Sign up today to read free research on
CDE at:
http://www.investor-edge.com/321-CDE-19Mar2014.pdf
Shares in Eagle Rock Energy Partners L.P. edged 12.87% higher,
finishing Tuesday's session at $5.35,
with 4.13 million shares traded as compared to a three months
average volume of 1.03 million shares. The stock fluctuated between
$4.76 and $5.39 during the trading
session. Shares in Eagle Rock Energy Partners L.P. have advanced
13.59% in the previous three trading sessions and 0.56% in the last
one month. The company's shares have lost 10.08% on YTD basis. The
S&P 500 Energy Sector Index mapped a gain of 0.78% during the
trading session and charted up 1.40% in the last one month.
Furthermore, the stock is trading at the RSI of 31.84 and below its
50-day and 200-day moving averages of $5.44 and $6.50,
respectively. Sign up today to read free research on EROC at:
http://www.investor-edge.com/321-EROC-19Mar2014.pdf
On Tuesday, shares in Idenix Pharmaceuticals Inc. ended the day at
$7.82, which is 8.46% higher than the
previous day's closing price of $7.21. A total of 2.51 million shares were traded
as compared to the three months average volume of 1.49 million
shares. During the session, the stock oscillated between
$7.21 and $8.11. Idenix
Pharmaceuticals Inc.'s shares have rallied 12.68% in the previous
three trading sessions, 52.44% in the last three months, and 30.77%
on YTD basis. The S&P 500 Health Care Sector Index advanced
1.17% during the trading session and charted up 1.47% in the last
one month. Further, the stock is trading at the RSI of 54.15 and
above its 50-day and 200-day moving averages of $7.04 and $5.16,
respectively. Sign up today to read free research on IDIX at:
http://www.investor-edge.com/321-IDIX-19Mar2014.pdf
WidePoint Corp.'s stock closed Tuesday's session at $1.76, up 8.64% with a trading volume of 2.59
million shares as compared to a three months average volume of 1.21
million shares. The stock traded between $1.65 and $1.79 during the session. The company's
shares traded at a PE ratio of 160.00 and have gone up 7.32% on YTD
basis. WidePoint Corp.'s shares have surged 16.56% in the last one
month and 20.55% in the previous three months. The S&P 500
Information Technology Sector Index mapped a gain of 1.35% during
the trading session and charted up 1.13% in the last one month.
Moreover, the stock is trading at the RSI of 56.23 and above its
50-day and 200-day moving averages of $1.57 and $1.08,
respectively. Sign up today to read free research on WYY at:
http://www.investor-edge.com/321-WYY-19Mar2014.pdf
===============
EDITOR'S NOTES:
===============
1. This is not company news. We are an independent source and our
views do not reflect the companies mentioned.
2. Information in this release is fact checked and produced on a
best efforts basis and reviewed by Nidhi Vatsal, a CFA
charterholder. However, we are only human and are prone to make
mistakes. If you notice any errors or omissions, please notify us
below.
3. This information is submitted as a net-positive to companies
mentioned, to increase awareness for mentioned companies to our
subscriber base and the investing public.
4. If you wish to have your company covered in more detail by our
team, or wish to learn more about our services, please contact us
at pubco [at] http://www.investor-edge.com.
5. For any urgent concerns or inquiries, please contact us at
compliance [at] http://www.investor-edge.com.
6. Are you a public company? Would you like to see similar coverage
on your company? Send us a full investors' package to research [at]
http://www.investor-edge.com for consideration.
COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis.
This document, article or report is prepared and authored by
Investor-edge. An outsourced research services provider represented
by Nidhi Vatsal, CFA, has only reviewed the information provided by
Investor-edge in this article or report according to the Procedures
outlined by Investor-edge. Investor-edge is not entitled to veto or
interfere in the application of such procedures by the outsourced
provider to the articles, documents or reports, as the case may
be.
NOT FINANCIAL ADVICE
Investor-edge makes no warranty, expressed or implied, as to the
accuracy or completeness or fitness for a purpose (investment or
otherwise), of the information provided in this document. This
information is not to be construed as personal financial advice.
Readers are encouraged to consult their personal financial advisor
before making any decisions to buy, sell or hold any securities
mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Investor-edge is not responsible for any error which may be
occasioned at the time of printing of this document or any error,
mistake or shortcoming. No liability is accepted by Investor-edge
whatsoever for any direct, indirect or consequential loss arising
from the use of this document. Investor-edge expressly disclaims
any fiduciary responsibility or liability for any consequences,
financial or otherwise arising from any reliance placed on the
information in this document. Investor-edge does not (1) guarantee
the accuracy, timeliness, completeness or correct sequencing of the
information, or (2) warrant any results from use of the
information. The included information is subject to change without
notice.
CFA® and Chartered Financial Analyst® are registered trademarks
owned by CFA Institute.
SOURCE Investor-Edge